Wei Nie

Phase 1b Study of Sintilimab Plus Anlotinib as First-line Therapy in Patients With Advanced NSCLC

Tianqing Chu, Runbo Zhong, Hua Zhong et al. · Journal of Thoracic Oncology · 2021 · 226 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +4

Overexpression of stathmin 1 is a poor prognostic biomarker in non-small cell lung cancer

Wei Nie, Midie Xu, Lu Gan et al. · Laboratory Investigation · 2014 · 78 citations · Full text

Medicine, Cancer Biology, Oncology +10

Racial differences in characteristics and prognoses between Asian and white patients with nonsmall cell lung cancer receiving atezolizumab: An ancillary analysis of the POPLAR and OAK studies

Jie Qian, Wei Nie, Jun Lü et al. · International Journal of Cancer · 2019 · 68 citations · Full text

Medicine, Immunology, Oncology +16

Chromatin accessibility analysis reveals that TFAP2A promotes angiogenesis in acquired resistance to anlotinib in lung cancer cells

Lele Zhang, Jun Lü, Ruiqi Liu et al. · Acta Pharmacologica Sinica · 2020 · 61 citations · Full text

Medicine, Molecular Biology, Oncology +14

hsa_circ_0003222 accelerates stemness and progression of non-small cell lung cancer by sponging miR-527

Changhui Li, Jiaqi Zhang, Xiaohua Yang et al. · Cell Death and Disease · 2021 · 59 citations · Full text

Medicine, Cancer Biology, Oncology +17